Middle Meningeal Artery Embolization for Chronic Subdural Hematoma-A New Treatment Paradigm?

Review Clinical Neurology

Management of Chronic Subdural Hematoma: A Systematic Review and Component Network Meta-analysis of 455 Studies With 103 645 Cases

Jack Henry et al.

Summary: The study found that the recurrence rate of chronic subdural hematoma (CSDH) after surgical treatment is approximately 10%. Pharmacological treatments and surgical interventions reduce the risk of recurrence, but the use of corticosteroids is associated with increased morbidity.

NEUROSURGERY (2022)

Add to Collection

Editorial Material Medicine, General & Internal

Methods of Public Health Research - Strengthening Causal Inference from Observational Data

Miguel A. Hernan

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Clinical Neurology

Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature

D. J. Stubbs et al.

Summary: The incidence of cSDH is on the rise, with a projected 53% increase in operative caseload within our region by 2040. These findings are important for guiding future healthcare planning.

ACTA NEUROCHIRURGICA (2021)

Add to Collection

Article Clinical Neurology

Derivation of a Clinical Score for Prediction of Recurrence Following Evacuation of Chronic Subdural Hematoma: A Retrospective Cohort Study at a National Referral Centre

Michael Amoo et al.

Summary: Evaluation of patient and radiologic factors can predict the recurrence of chronic subdural hematoma. A scoring system was derived from the study to identify patients who may benefit from routine postoperative surveillance imaging.

WORLD NEUROSURGERY (2021)

Add to Collection

Review Clinical Neurology